Examining lung inflammation differences in smokers and vapers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to measure lung inflammation levels among different groups using a radioactive tracer called [18F]NOS. Participants will undergo a PET/CT scan to visualize how the tracer accumulates in the lungs, allowing researchers to compare inflammation between e-cigarette users, cigarette smokers, and non-smokers. Blood samples will also be collected to assess inflammation markers and tracer concentration during the scan. The study is conducted under an FDA-approved Investigational New Drug Application.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Participants will be 18-45 years of age
2. Subject must meet one of the following criteria:

   NIC vapers: current e-cigarette use of nicotine at least 5 days per week for the past year, no current combustible cigarette use, cannabis vaping, or cannabis smoking during the 30 days prior to study enrollment

   CAN vapers: current e-cigarette use of cannabis at least 5 days per week for the past year, no current combustible cigarette use, cannabis smoking, or nicotine vaping during the 30 days prior to study enrollment

   Cigarette smokers: current cigarette smoking of at least 5 cigarettes per day, 4 days per week for the past year with no e-cigarette use (cannabis or nicotine) during the 30 days prior to study enrollment

   Dual combustible and e-cigarette users: current e-cigarette use of cannabis and/or nicotine at least 5 days per week for the past year with cigarette or cannabis smoking during the 30 day prior to study enrollment

   Non-Smokers: reported non-smoking history or \< 100 lifetime cigarettes, \< 100 e-cigarette use episodes, and \< 100 lifetime cannabis use episodes
3. Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.

Exclusion Criteria:

1. Females who are pregnant or breast feeding at the time of screening will not be eligible for this study; a urine pregnancy test will be performed in women of child-bearing potential at screening and on scan day.
2. Current untreated and unstable diagnosis of substance use disorder, except nicotine use disorder or cannabis use disorder
3. Positive urine drug screen for opiates, methamphetamine or cocaine at screening
4. Current unstable and/or untreated major depression or psychotic disorder per medical record review or self-reported
5. Use of inhaled or oral corticosteroids or anti-inflammatory medications per medical record review or self-report
6. History of lung trauma
7. Active (or within the previous 4 weeks of screening) lung infection or lung disease that impact uptake of \[18F\]NOS (e.g. tuberculosis, cystic fibrosis)
8. Inability to tolerate imaging procedures in the opinion of an investigator or treating physician
9. Any current or past medical condition, illness, or disorder as assessed by medical record review and/or self-reported that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study

Where it's running

• University of Pennsylvania
  Philadelphia, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Jacob Dubroff, MD, PhD — University of Pennsylvania
• Study coordinator: Erin Schubert
• Email: erinschu@pennmedicine.upenn.edu
• Phone: 215-573-6569

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

• Promoting breastfeeding to prevent postpartum smoking relapse

  This study tests whether a breastfeeding promotion program can help ex-smokers stay smoke-free after giving birth.

  Recruiting State University of New York at Buffalo · Buffalo, New York · NCT07661550

• Communal coping in couples where both partners smoke during a quit attempt

  This project tests whether couples who tackle quitting as a team (communal coping) fare better when one partner in a smoking couple tries to quit.

  Recruiting University of Colorado, Denver · Denver, Colorado · NCT07553962

• Non-surgical gum treatment effects on saliva markers in smokers and non-smokers with periodontitis

  This test will see if deep cleaning (scaling and root planing) changes saliva markers linked to bone loss in adults with Stage II–III periodontitis, comparing current smokers and non-smokers.

  Recruiting at 2 sites Al-Mustansiriyah University · Baghdad, Baghdad Governorate and 1 other locations · NCT07547202

• Using lung cancer screening CT scans to find COPD (MAP2)

  This project will use lung cancer screening CT scans and spirometry in current and former smokers aged 50–80 with at least 20 pack-years to see if CT findings can identify people who have COPD.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07482475

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.